Brief: Theraclion announces positive study results for Echopulse treatment
Oct 15 (Reuters) - Theraclion SA ALTHER.PA :
* Says clinical study results demonstrate significant
acceleration of Echopulse treatment due to new beamotion
technology
* Comparison with treatment duration data from existing
procedure indicate that beamotion is up to 5 times faster than
previous technology
Source text for Eikon: ID:nBw9Tt6Xba
Further company coverage: ALTHER.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Theraclion SA
See all newsBrief: Theraclion Appoints Claude Lenoir As Interim Chairman
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO